The US is the bigger Anesthesia & Respiratory Devices market: $12.1 Bn against $2.3 Bn in 2023, about 5.3 times as large.
Canada grows faster: 9.5% a year, against 7.5%. The gap still grows from $9.8 Bn to $19.2 Bn by 2033.
Clinical research: 110 active trials in the US, 39 in Canada.
| Measure |  US |  Canada |
|---|---|---|
| Market size, 2023 | $12.1 Bn | $2.3 Bn |
| Market size, 2033 projected | $24.8 Bn | $5.7 Bn |
| Growth a year (CAGR) | 7.5% | 9.5% |
| Money added, 2023–2033 | $12.8 Bn | $3.4 Bn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #3 |
| Market per person, 2023 | $35 | $55 |
| Active clinical trials | 110 | 39 |
| Full report | US report | Canada report |
Year by year, 2023 to 2033
US Canada · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Anesthesia & Respiratory Devices, US or Canada?
The US is the bigger Anesthesia & Respiratory Devices market: $12.1 Bn against $2.3 Bn in 2023, about 5.3 times as large.
Which grows faster in Anesthesia & Respiratory Devices, US or Canada?
Canada grows faster: 9.5% a year, against 7.5%. The gap still grows from $9.8 Bn to $19.2 Bn by 2033.
More Anesthesia & Respiratory Devices comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.